Bengaluru, June 17 -- India's pharmaceutical sector is a global powerhouse, ranking third in production volume and supplying 20% of the world's generic medicines. In 2023-24, the sector's turnover reached Rs.4,17,345 crore, with annual growth exceeding 10% for five years. Recent data show 7.8% year-on-year growth in April 2025, driven by strong demand and new products.

Nifty Pharma declined by 416 points (1.81%) to 21,639.85, following reports that US President Donald Trump plans to impose pharma tariffs soon. The announcement triggered export disruptions, pressuring Indian pharmaceutical stocks and dampening sentiment across the sector.

Pharma stocks experienced heightened volatility after U.S. President Donald Trump announced a new wa...